SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

GOOGL is trending as traders debate the impact of heavy AI capital expenditure on the company's fundamentals, with some expressing frustration over recent downward price movement despite strong cloud revenue growth. The conversation remains polarized between those viewing the decline as a buying opportunity and those concerned about valuation and sustained selling pressure.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

Compass Pathways is trending as investors monitor upcoming catalysts, including second-quarter financial results, a rolling NDA submission, and potential FDA approval for its psilocybin-based depression treatment. While some participants express bullish sentiment due to the company's first-mover advantage and strong cash position, others cite broader market volatility and regulatory hurdles as risks to the stock's near-term performance.

Casey's General Stores, Inc. engages in the provision of management and operation of convenience stores and gasoline stations. It provides self-service gasoline, a wide selection of grocery items, and an array of freshly prepared food items. The firm offers food, beverages, tobacco products, health and beauty aids, automotive products, and other non-food items. The company was founded by Donald F. Lamberti in 1968 and is headquartered in Ankeny, IA.

Casey`s General Stores, Inc.

Casey's shares declined sharply following their latest earnings report as investors reacted to slower same-store sales growth and the company's decision to maintain, rather than raise, its full-year guidance despite an earnings beat. While some market participants express frustration over the valuation and cooling growth metrics, others view the pullback as a buying opportunity, citing the company's long-term operational track record and dominant convenience-store model.

Chewy, Inc. operates as an online retailer of pet food and other pet-related products and services. It supplies pet medications, food, treats and other pet-health products and services for dogs, cats, fish, birds, small pets, horses, and reptiles. It has a portfolio of pet healthcare offerings that includes Chewy Pharmacy, Connect with a Vet, and CarePlus, an exclusive suite of pet-first insurance and wellness plans. The company was founded by Ryan Cohen and Michael Day in September 2011 and is headquartered in Plantation, FL.

Chewy Inc - Ordinary Shares - Class A

Chewy Inc

Chewy is trending as investors react to the company's recent Q1 financial results and mixed analyst outlooks, with some traders debating its long-term potential amid concerns over consumer spending, while others focus on its recurring revenue model and valuation as a potential turnaround play. The community sentiment remains divided between those viewing the stock as heavily oversold and those concerned about persistent downward trends and management's growth guidance.

Oddity Tech Ltd. engages in the online retail sale of cosmetics and beauty products. Its products include lipsticks, makeup brushes, mascara, eyelash curlers, and makeup brush cleansers. The company was founded by Oran Holtzman and Shiran Holtzman-Erel on March 23, 2013 and is headquartered in Tel Aviv, Israel.

ODDITY Tech Ltd. - Ordinary Shares - Class A

ODDITY Tech is experiencing significant volatility as traders react to a steep decline following an earnings report that highlighted a 30% revenue drop for the first quarter, which management attributed to advertising algorithm issues and increased customer acquisition costs. While some in the community see the sharp sell-off as an overreaction that presents a value opportunity, particularly given the company's strong cash position and ongoing share buyback program, others are skeptical and wary of the company's long-term guidance and potential for further downside.

Nokia Oyj engages in the provision of network infrastructure, technology, and software services. It operates through the following segments: Mobile Networks, Network Infrastructure, Cloud and Network Services, and Nokia Technologies. The Mobile Networks segment offers technologies for Radio Access Networks (RAN) as well as Microwave Radio Links (MWR) for transport networks. The Network Infrastructure serves communication service providers, enterprises, webscales and public sector customers. The Cloud and Network Services segment builds around software and the cloud and is focused on driving leadership in cloud-native software and as-a-service delivery models, as demand for critical networks accelerates; and with strong market positions in communications software, private wireless networks, and cognitive (or intelligent) services. The Nokia Technologies segment, building on decades of innovation and R&D leadership in technologies used in virtually all mobile devices used today, is expanding the Nokia patent licensing business, reintroducing the Nokia brand to smartphones through brand licensing, and establishing a technology licensing business. The company was founded by Fredrik Idestam in 1865 and is headquartered in Espoo, Finland.

Nokia Corp - ADR

Nokia Corp

Nokia is trending following reports that the company will supply infrastructure for Google's data center expansion in Finland and its upcoming return to the Euro Stoxx 50 index. Traders are expressing mixed sentiment, with some highlighting these developments as bullish catalysts while others remain skeptical due to the stock's sluggish historical performance and large share count.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is trending as investors weigh the upcoming product event, specifically speculation surrounding a potential foldable iPhone and the debut of the new CEO, against historical patterns of 'sell the news' price pressure. While some traders are positioning for a run-up ahead of the event, others are bearish, citing concerns over high valuation, lack of innovation, and production challenges.

ServiceTitan, Inc. engages in the collection of field service activities required to install, maintain, and service the infrastructure and systems of residences and commercial buildings. The company was founded by Ara Mahdessian and Vahe Kuzoyan on June 8, 2008 and is headquartered in Glendale, CA.

ServiceTitan Inc. - Ordinary Shares - Class A

ServiceTitan 

ServiceTitan shares fell sharply following second-quarter earnings that beat revenue and earnings expectations, but were overshadowed by a weaker-than-expected third-quarter revenue outlook and a management transition involving the Chief Revenue Officer. Traders are debating whether the sell-off is an overreaction to minor guidance adjustments or a justified cooling of a high-valuation software growth story.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth is trending as investors react to a recent earnings beat and improved full-year guidance, with many traders framing the stock as a defensive "safe haven" amidst broader market volatility. While some sentiment remains cautious due to ongoing regulatory scrutiny and historical price manipulation concerns, the community is largely focused on upward price targets and potential sector rotation as shares attempt to reclaim the $450 level.

Alphabet Inc - Ordinary Shares - Class C

Alphabet shares are facing downward pressure as investors express concerns over intense competition in AI, high capital expenditure, and perceived leadership challenges, leading to sustained selling despite its robust cloud growth. Sentiment remains polarized, with some traders viewing the current valuation as a buying opportunity while others anticipate further declines amid broader market volatility and macroeconomic uncertainty.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CMPS Stock Rallies On Launch-Prep Push Ahead Of FDA Psychedelics Hearing

The share price moved following a commercial-readiness announcement, as the company prepares to debut a U.S. doctor education campaign and participate in upcoming healthcare industry conferences. This push is being viewed by investors as a positive signal ahead of a significant FDA public hearing regarding the future therapeutic use of psychedelic drugs.

Compass Pathways New 52-Week Topline Open-Label Data from Phase 3 COMP005 Trial Demonstrates Additional Benefit from Another COMP360 Dose in Part C Extending Durability Out to 1 Year

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today the topline 52-week results (Part C) from its Phase 3 COMP005 trial of COMP360, a synthetic, proprietary formulation of psilocybin, for...

CMPS Stock Rallies On Launch-Prep Push Ahead Of FDA Psychedelics Hearing  

Equity

Compass has said a rolling FDA application is already underway for its COMP360, with the package due to be completed in the fourth quarter of 2026 and a possible U.S. launch in the first half of 2027. 


Compass Pathways to Debut U.S. HCP Education Campaign and Present New HEOR Data at Psych Congress 2026

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, today announced its participation at Psych Congress 2026, taking place in New Orleans, LA, from September 14-19. The Company will debut Change the Tune in...

Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to thirty-one newly hired non-executive employees...

Compass Pathways Recognized as a 2026 Fierce 50 Breakthrough Honoree

Compass Pathways, a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, has been named a 2026 Fierce 50 Breakthrough honoree by Fierce Pharma, Fierce Biotech and Fierce Healthcare. The Fierce 50 recognizes 50 individuals and organizations...

Compass Pathways to Participate in 2026 Cantor Global Healthcare Conference on September 9, 2026

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that management will attend the 2026 Cantor Global Healthcare Conference on September 9, 2026 and will participate in a fireside chat at...

CMPS Stock Clocks 25% Gains In August Ahead Of Application Filing For Drug, FDA Hearing On Psychedelics

The most closely watched next step for Compass is the completion of its application to the U.S. Food and Drug Administration for COMP360, its synthetic psilocybin treatment aimed at people with depression that has not responded to other options.

COMPASS Pathways (CMPS) Q2 2026 Earnings Call Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

Compass Pathways to Participate in Canaccord Genuity's 46th Annual Growth Conference on August 12, 2026

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that management will attend the Canaccord Genuity's 46th Annual Growth Conference on August 12, 2026, and will participate in a fireside...

Compass Pathways Working with U.S. Department of Veterans Affairs for Investigational Study of Psilocybin

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today it is working with the U.S. Department of Verterans Affairs (VA) on a multi-site randomized controlled clinical trial. The study will...

Extremely Bullish Sentiment

$CMPS

$SOUN

$MRNA

$LCID

Compass Pathways ($CMPS), SoundHoundAI ($SOUN), Moderna ($MRNA), and Lucid Group ($LCID) are four of the most searched and talked-about stocks among retail investors this morning. Which are you most bullish? Drop your reasoning in the comments.

Which of these trending stocks are you most bullish on for the next 5 years - $CMPS, $SOUN, $MRNA, or $LCID?

Stocktwits

SoundHound AI Inc

Moderna Inc

Lucid Group Inc

Which of these trending stocks are you most bullish on for the next 5 years - 

Stocktwits Polls

Investors are closely monitoring an upcoming Q4 rolling NDA submission and key FDA leadership appointments for potential accelerated approval.

Strong after-hours momentum and technical chart patterns, such as bull flags, have traders eyeing a surge past the $15 resistance level.

Compass is ramping up its public profile with new healthcare provider education campaigns and multiple upcoming industry conference presentations.

Shareholders are buzzing with rumors of potential acquisition by big pharma post-approval, with price targets ranging up to $36 per share.

Feed

News

Sentiment

Earnings

Fundamentals

Info

CMPS COMPASS Pathways

Fundamentals

Latest CMPS News